期刊文献+

α-2b干扰素抑制动脉粥样硬化的实验研究 被引量:1

Inhibitory effect of interferon α-2b on atherosclerosis
下载PDF
导出
摘要 目的 :探讨α - 2b干扰素 (IFNα- 2b)抑制动脉粥样硬化 (AS)的体内机制。方法 :随机将家兔分为空白对照 (NC)组、动脉粥样硬化 (AS)组、病毒感染动脉粥样硬化 (V)组、干扰素治疗非病毒感染动脉粥样硬化 (IFN -Ⅰ )组、干扰素治疗病毒感染动脉粥样硬化 (IFN -Ⅱ )组。复制AS模型 ,于第 1、3、5、7周酶法测血清总胆固醇、甘油三脂。 7周后主动脉苏丹Ⅳ染色测AS斑块面积 /总面积 ,HE染色观察主动脉形态学改变。用免疫组化法测胸主动脉中的增殖细胞核抗原 (PCNA)和单纯疱疹病毒Ⅰ型 (HSV -Ⅰ )的表达 ,用原位杂交法测血小板衍生生长因子 β(PDGF - β)的表达程度。 结果 :NC组、IFN -Ⅰ组、IFN -Ⅱ组主动脉粥样硬化斑块面积小于AS组 (P <0 .0 5) ,AS组小于V组 (P <0 .0 5)。NC组、IFN -Ⅰ组、IFN -Ⅱ组PDGF -B的表达低于AS组、V组 (P <0 .0 5)。结论 :病毒可能是AS的始动因素 ,PDGF - β可能是促使血管平滑肌细胞 (VSMC)增生、AS进展的主要因素。IFNα- 2b通过抑制病毒和下调PDGF - βmRNA抑制VSMC的增生 ,可能是其抑制AS的形成及发展的重要机制之一。 AIM: To evaluate the effects of interfer α-2b (IFN α-2b ) on atherosclerosis(AS).METHODS: Thirty normal male rabbits were randomly divided into five groups:normal control group(NC group, n= 6), atherosclerosis group(AS group, n =6),virus (herpesvirus Ⅰ,HSV-Ⅰ)infected atherosclerosis group(V group, n= 6), interferon (interferon α-2b) intervented atherosclerosis group (IFN-Ⅰgroup, n= 6),interferon intervented and virus infected atherosclerosis group (IFN-Ⅱ group, n= 6). Serum lipids were measured and the thoracic aortas were sampled for histopathological, immunohistochemical and in situ hybridization study. RESULTS: The aorta atherosclerosis areas of NC, IFN-Ⅰ and IFN-Ⅱ groups were lower than that of AS group significantly, respectively, and the area of AS group was lower than that of V group ( P< 0.05). Platelet-derived growth factor B-chain (PDGF-β) expression was reduced both in IFN-Ⅰand IFN-Ⅱ groups( P< 0.05). CONCLUSIONS: Our data provide evidence that virus could cause atherosclerosis, and the AS formation could be inhibited by IFN α-2b through its antivirus effect and inhibitory effect on PDGF-β and VSMC proliferation.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2003年第2期219-222,T005,共5页 Chinese Journal of Pathophysiology
基金 湖北省科技委员会资助项目 (SK - 962P1 1 0 2 )
关键词 动脉粥样硬化 疱疹病毒I型 血小板源生长因子 干扰素alfa-2B Atherosclerosis Herpesvirus Ⅰ Platelet-derived growth factor Interferon alfa-2B
  • 相关文献

参考文献1

二级参考文献5

共引文献4

同被引文献11

  • 1胡强,马岚青,赵莹,黄尤光,李树德.肝肾疾病对血浆同型半胱氨酸水平的影响[J].昆明医学院学报,2007,28(2):99-101. 被引量:2
  • 2LENTZ S R. Homocysteine and vascular dysfunction[J].Life Sci, 1997,61 : 1205 - 1215
  • 3REFSUM H, UELAND P M, NYGARD O, et al. Homocysteine and cardiovascular disease [ J ]. Annu Rev Med, 1998,4-9:31 - 62
  • 4ZOU C G, BANERJEE R. Homocysteine and redox signaling [J]. Antioxid Redox Signal,2005,7(5 - 6) : 547 -559.
  • 5ELA-MOREIRAS G, ALONSO-APERTE E, VARRUBIO M, et al. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia:effect of S-adenosylmethionine treatment [J]. Hepatology, 1995,22(4) : 1310 - 1315
  • 6BOSY-WESTPHAL A, PETERSEN S, HINRICHSEN H, et al. Increased plasma homocysteine in liver cirrhosis [J]. Hepatol Res,2001,20:28 - 38
  • 7GARCIA-TEVIJANO E R, BERASAIN C, ROD- RIGUEZ J A,et al. Hyperhomocysteinemia in liver cirrhosis Mechanisms and role in vascular and hepatic fibrosis [ J ]. Hypertension, 2001,38 : 1217 - 1221
  • 8ZOU C G, BANERJEE R. Tumor necrosis factor -induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis[J]. J Biol Chem, 2003,278 : 16802 - 16808
  • 9ROBERT K, CHASSE J F, SANTIARD-BARON D, et al. Altered gene expression in liver from a murine model of hyperhomocysteinemia[J].J Biol Chem,2003,278:31501- 31511
  • 10VENTURAP, ROSA M C, ABBATI G, et al. Hyperhom - ocysteinaemia in chrnic liver diseases: role of stage disease, vitamin status and methylenetetra- hdrodolate reductase genetics [J]. Liver International,2005,25: 49 - 56

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部